From: Immunohistochemical expression of promyelocytic leukemia body in soft tissue sarcomas
No. | Age (yrs) | Gender | Site | Histological subtype | Histological grade | Tumor size (cm) | Surgical margin | Recurrence | Metastasis | Prognosis | Period (months) | PML (%) | PML expression |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 35 | female | popliteal | myxoid | 2 | 14 | marginal | - | - | CDF | 65 | 0.0 | - |
2 | 50 | female | thigh | myxoid | 3 | 6 | wide | - | - | CDF | 55 | 2.2 | + |
3 | 48 | female | forearm | myxoid | 2 | 8 | marginal | - | - | CDF | 12 | 3.0 | + |
4 | 66 | female | lower leg | dedifferentiated | 3 | 8 | marginal | - | - | CDF | 56 | 0.0 | - |
5 | 66 | male | upper arm | myxoid | 3 | 11 | wide | - | - | CDF | 40 | 0.0 | - |
6 | 60 | male | thigh | myxoid | 2 | 16 | wide | - | - | CDF | 47 | 1.4 | + |
7 | 74 | male | thigh | myxoid | 3 | 8 | wide | - | + | DOD | 27 | 1.2 | + |
8 | 60 | male | thigh | pleomorphic | 3 | 10 | wide | - | - | CDF | 132 | 0.0 | - |
9 | 51 | male | thigh | round cell | 3 | 9 | wide | - | + | DOD | 12 | 2.1 | + |
10 | 66 | male | shoulder | myxoid | 2 | 8 | wide | - | - | CDF | 70 | 2.0 | + |
11 | 68 | male | thigh | myxoid | 3 | 12 | marginal | - | - | CDF | 120 | 0.0 | - |
12 | 43 | female | thigh | myxoid | 2 | 8 | wide | - | - | CDF | 60 | 0.0 | - |
13 | 47 | male | forearm | dedifferentiated | 3 | 11 | marginal | - | + | DOD | 12 | 1.2 | + |
14 | 62 | female | thigh | myxoid | 2 | 15 | wide | - | - | CDF | 62 | 1.7 | + |
15 | 67 | female | thigh | myxoid | 2 | 15 | wide | - | - | CDF | 60 | 0.4 | + |
16 | 63 | male | thigh | pleomorphic | 2 | 12 | marginal | - | - | CDF | 54 | 2.0 | + |
17 | 73 | female | buttock | myxoid | 2 | 8 | wide | - | - | CDF | 65 | 0.0 | - |
18 | 52 | female | thigh | myxoid | 3 | 6 | wide | - | - | CDF | 49 | 1.5 | + |
19 | 48 | male | thigh | myxoid | 2 | 20 | marginal | + | + | DOD | 15 | 5.2 | + |